activation of mitogen-activated protein kinases (MAPKs) and NF-B, leading to the production of proinflammatory cytokines (13) . However, some E. faecalis strains isolated from the gastrointestinal tracts of healthy human infants can suppress MAPK and NF-B signaling and interleukin-8 (IL-8) expression in intestinal epithelial cells in vitro (14, 15) .
Several E. faecalis virulence factors modulate immunity during infection, including aggregation substance (AS), gelatinase, and TcpF (16) (17) (18) (19) . TcpF is a TIR domaincontaining protein and interferes with Toll-like receptor (TLR)-MyD88 interactions, which also depend on MyD88 TIR domain-mediated interactions. As a result, E. faecalis TcpF expression results in decreased NF-B p65 translocation in RAW macrophages (16, 20) . Plasmid-encoded AS promotes phagocytosis and internalization into macrophages via interaction with complement receptor type 3 (21) (22) (23) . After internalization, AS promotes resistance to superoxide killing, leading to increased survival in macrophages (19) . In addition, gelatinase is a secreted, quorum-responsive gene product that facilitates innate immune evasion by cleaving complement components C3, C3a, and C5a to reduce opsonization and decrease neutrophil recruitment (17, 18, 24, 25) .
In a mouse urinary tract infection (UTI) model, the cellular response to E. faecalis infection is primarily monocytic and is independent of TLR2 (26) . In a CAUTI model, the presence of a urinary catheter alone elicits a strong proinflammatory response in the bladder, composed of neutrophils and monocyte-derived cells (27) (28) (29) . Infection of catheterized bladders with E. faecalis results in the development of high-titer catheterassociated biofilms and bladder infection despite the presence of a strong inflammatory response induced by catheterization (19) . Moreover, in the course of E. faecalis CAUTI, the number of activated bladder-associated macrophages is significantly decreased compared to that in catheterized, uninfected animals (27) . Together these observations suggest that E. faecalis can subvert immune-mediated killing to persist within the infected bladder.
During UTI and CAUTI, E. faecalis is often part of a polymicrobial community (30) (31) (32) . E. faecalis can promote polymicrobial infection by increasing the resistance of coinfecting organisms, such as Pseudomonas aeruginosa and Proteus mirabilis, to clearance by antibiotics (33, 34) . Polymicrobial infection by E. faecalis and P. aeruginosa leads to aggravated pyelonephritis more often than monomicrobial infection does (33) . E. faecalis and uropathogenic Escherichia coli (UPEC) are also frequently isolated together during CAUTI (35) ; however, the relationship between these pathogens and its impact on pathogenesis are unknown. Given the frequency with which E. faecalis is found within polymicrobial infections and that E. faecalis can modulate the host immune response within the catheterized bladder, we tested the hypothesis that E. faecalis immune modulation promotes polymicrobial CAUTI. We found that E. faecalis actively subverts E. coli-mediated NF-B activation and proinflammatory cytokine production in RAW264.7 macrophages in vitro and macrophage-associated proinflammatory expression profiles in catheterized bladders in vivo, culminating in higher-titer E. coli CAUTI.
RESULTS
Live E. faecalis prevents lipopolysaccharide (LPS)-or lipoteichoic acid (LTA)-mediated NF-B-driven activation in RAW macrophages. E. faecalis infection during CAUTI induces monocytic infiltration (27) . To determine whether E. faecalis immunomodulates monocyte-derived cells, such as macrophages, we assessed NF-B signaling in mouse RAW264.7 macrophages at 6 h postinfection (hpi). Both E. faecalis strain OG1RF (Fig. 1A) and the multidrug-resistant strain V583 (see Fig. S1A in the supplemental material) activated NF-B at low multiplicities of infection (MOIs), as previously reported (13) . In contrast, neither E. faecalis OG1RF nor V583 activated NF-B signaling at high MOIs. We simultaneously monitored lactate dehydrogenase (LDH) release into culture supernatants to ensure that the absence of NF-B activation was not a result of cell death at high MOIs, and we observed no increase in LDH release at any of the MOIs used in this study ( Fig. 1B; Fig. S1B ).
E. faecalis can attenuate proinflammatory cytokine secretion in intestinal epithelial cells (15) . To determine whether E. faecalis actively prevented NF-B-mediated tran-scription or simply failed to induce NF-B-mediated transcription at high MOIs in macrophages, we tested whether E. faecalis could prevent NF-B-driven activation in the presence of TLR agonists that initiate NF-B signaling. We exposed macrophages to LPS or LTA simultaneously with E. faecalis for 6 h, quantified both NF-B-mediated transcription and LDH release, and observed a dose-dependent inhibition of LPS-and LTA-induced NF-B activation by E. faecalis ( Fig. 1C and E; Fig. S1C ), in the absence of cytotoxicity ( Fig. 1D and F; Fig. S1D ).
To determine whether the absence of an NF-B transcriptional response was due to an E. faecalis secreted factor, we examined the macrophage response to heat-killed E. faecalis or cell-free bacterial supernatants at MOI equivalents ranging from 1 to 100. We observed that heat-killed E. faecalis activated NF-B at all MOIs, in an inverse manner to that for live intact cells (Fig. 1G) , in the absence of cytotoxicity (Fig. 1H) . Supernatants from infected macrophages showed NF-B activation similar to that of live E. faecalis cells (Fig. 1G) . To rule out the possibility that NF-B activation was not due to cytokines secreted by RAW264.7 macrophages during infection, we also exposed macrophages to supernatants from bacterial cultures grown in the absence of macrophages. Superna-tants from bacterial cultures weakly activated NF-B alone and did not suppress LPS-mediated induction of NF-B activity, except at an MOI of 100 (Fig. 1G) . Together, these data suggest that E. faecalis actively prevents NF-B activation via a process requiring a heat-modifiable factor that is secreted into cell supernatants during coculture with macrophages and that is produced in the absence of macrophages only at very high MOIs.
After determining that the bacterial factor involved in immunomodulation is secreted and heat modifiable, we examined the roles of several factors previously implicated in immune modulation or interactions with phagocytes. The gelatinase encoded by gelE is induced and secreted at high cell densities, akin to the high-celldensity NF-B activity modulation we observed, and is regulated by the fsr quorum sensing system (18, 25, 36) . Multiple peptide resistance factor (MprF) is involved in evading killing by phagocyte-associated antimicrobial peptides in E. faecalis (37, 38) and is implicated in virulence factor secretion in Listeria monocytogenes (39) . Therefore, we exposed macrophages to E. faecalis mutants in each factor simultaneously with LPS. However, we observed a dose-dependent suppression of NF-B for all mutants tested, similar to that of the parental OG1RF strain (Fig. S2) . Thus, the immunomodulation phenotype that we observed is likely due to another, uncharacterized secreted bacterial factor(s).
E. faecalis suppresses NF-B-dependent cytokine and chemokine production in RAW macrophages. E. faecalis modulates cytokines, such as IL-8, tumor necrosis factor alpha (TNF-␣), and IL-1␤, in intestinal epithelial cells (13, 14) . To investigate whether E. faecalis suppresses cytokine production in infected macrophages, we measured release in the absence of LPS of a variety of cytokines and chemokines whose expression is dependent on NF-B activation. We observed an overall increase of both pro-and anti-inflammatory cytokines and chemokines at MOIs of 10 and 1, similar to that observed in LPS-treated cells ( Fig. 2A and B) . Strikingly, at an MOI of 100, we observed a global decrease in cytokine, chemokine, and growth factor expression compared to that with an MOI of 10 or LPS exposure ( Fig. 2A) . Moreover, at an MOI of 100, we observed that most of the analytes (gamma interferon [IFN-␥], CCL11, CSF2, IL-4, IL-17, IL-12p40, IL-12p70, IL-2, IL-1␤, CCL2, CXCL1, and IL-5) were present at levels similar to those for the medium control ( Fig. 2A and B; Fig. S3A ). Principal component analysis of analytes revealed that the profile for an MOI of 100 overlapped the profile for uninfected macrophages, suggesting that analytes were not expressed despite greater numbers of E. faecalis organisms (Fig. S3B) . Therefore, these data suggest that E. faecalis suppression of NF-B activation at a high MOI led to an overall suppression of cytokine and chemokine expression (Fig. 2) .
E. faecalis limits E. coli-mediated immune activation during polymicrobial RAW macrophage infection. To investigate whether E. faecalis-mediated immune suppression contributed to polymicrobial UTI, we first tested its ability to suppress NF-B activity in the presence of E. coli in vitro. We determined that RAW macrophages infected with E. coli K-12 strain MG1655 at an MOI of 1 or with E. coli UTI89 at an MOI of 0.125 induced NF-B activation ( Fig. S4A and C) in the absence of cytotoxicity ( Fig.  S4B and D), whereas higher MOIs were toxic to the mammalian cells ( Fig. S4B and D) . In addition, we observed minimal NF-B activity for E. coli UTI89 at a high MOI, consistent with previous reports that the same strain is able to suppress the cytokine response in bladder epithelial cells and suggesting a general immunomodulatory capacity of this strain as well ( Fig. S4B and D) (40) . We then simultaneously infected macrophages with E. faecalis and E. coli at these predetermined MOIs and observed that while both E. coli strain MG1655 and UTI89 monoinfections induced NF-B reporter activity equal to that with LPS alone, E. faecalis prevented E. coli-induced NF-B activity in a dose-dependent manner (Fig. 3) . Importantly, E. coli and E. faecalis growth during planktonic coculture in the absence of macrophages was unaffected by the presence of the other organism (data not shown). From this observation, we hypothesized that E. faecalis could similarly suppress the host immune response in vivo.
E. faecalis limits E. coli-mediated immune activation during mixed-species infection. To investigate whether E. faecalis affects immune-related signaling in vivo,
we performed RNA expression profiling on whole bladders at 24 h postcatheterization and -infection. We chose the CAUTI model because we desired an infection model in which E. faecalis would be present at high titers. Whereas E. faecalis does not cause a robust or high-titer infection in the ascending model of UTI (26), it colonizes the catheter and bladder at high CFU in the CAUTI model (27) . We compared E. coli UTI89 monospecies infection to E. coli UTI89 and E. faecalis OG1RF coinfection at a 1:1 inoculum ratio. Of the 15,501 detectable genes (adjusted P value [P adj ] of Ͻ0.05), 2 genes (0.013%) demonstrated increased mRNA levels, while 53 genes (0.34%) demonstrated decreased mRNA levels, between coinfected mice and monoinfected mice. Of these differentially expressed genes, we observed that 31 genes mapped to Gene Ontology (GO) terms, namely, response to external biotic stimulus (GO:0043207), response to other organism (GO:0051707), innate immune response (GO:0045087), response to cytokine (GO:0034097), response to biotic stimulus (GO:0009607), immune effector response (GO:0002252), and regulation of immune response (GO:0050776), that were significantly enriched (P adj Ͻ 0.01; Fisher's exact test, corrected for the 218 terms tested [see Materials and Methods]) ( Fig. 4A and B ; Table S1 ).
The enrichment of GO terms associated with immune function within downregulated genes during coinfection in the presence of E. faecalis suggested that we might also observe differential gene expression specifically in genes associated with the cell populations responding to CAUTI (29) . To test this, we examined the Immunological Genome Project (ImmGen) database, which comprises publicly available data from a collection of immune cell types in C57BL/6J mice (13, 41). We found that within the top
FIG 3 E. faecalis suppresses E. coli-induced immune activation in vitro.
Mouse RAW267.4 macrophages were stimulated simultaneously with E. faecalis OG1RF and E. coli MG1655 for 6 h prior to measurement of NF-B-driven SEAP reporter activity (A) and LDH activity (B). Mouse RAW267.4 macrophages were coinfected with E. faecalis OG1RF and E. coli UTI89 before measurement of NF-B-driven SEAP reporter activity (C) and LDH activity (D). For NF-B-driven SEAP reporter assays, exposure to medium alone (Ϫ) represents background NF-B reporter activity, and stimulation with LPS represents a positive control for reporter activity. For LDH assays, Triton X treatment served as a positive control (ϩ) for cell death. Data from 3 independent experiments were combined; mean values were graphed, and error bars represent SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test for multiple comparisons. ***, P Ͻ 0.001; ****, P Ͻ 0.0001; #, P Ͻ 0.05; ###, P Ͻ 0.001; ####, P Ͻ 0.0001. Asterisks are for comparisons to medium-only controls, and number (#) symbols are for comparisons to an MOI of 100. (Continued on next page) 50 differentially regulated genes between the monoinfected and coinfected groups, genes specific for dendritic cells, macrophages, and monocytes were overrepresented and showed decreased mRNA levels in coinfected animals, suggesting a reduced infiltration or activation of these cells in the bladder following coinfection compared to that following monoinfection ( Fig. 4C; Table S2 ).
E. faecalis limits E. coli-mediated immune activation and promotes E. coli virulence during mixed-species CAUTI. Based on downregulation of transcripts associated with interferon regulation (oas and ifi) and monocytic chemotaxis (CCL12) during E. faecalis-mediated immune suppression in vivo, we hypothesized that suppression allows UPEC to better colonize the bladder in the presence of E. faecalis. To test this in a CAUTI model, we coinfected catheterized mice with 10 7 CFU of E. faecalis OG1RF and 10 7 CFU of E. coli UTI89 and observed no significant differences in E. coli titers compared to those for monomicrobial E. coli infection (Fig. 5A and B) . In contrast, E. faecalis titers during coinfection were significantly lower in the bladder but not in the kidneys, which could be a result of tissue tropism of E. faecalis for the kidneys or due to enhanced clearance as a result of the E. coli-driven immune activation, as previously described for E. coli-group B streptococcus coinfection in the bladder (Fig. 5A and B ) (26, 42) . We postulated that the immunomodulatory capability of UPEC strain UTI89 may be sufficient to cause high-titer CAUTI such that E. faecalis cannot further augment infection (40) . Therefore, we hypothesized that colonization by a nonpathogenic, commensal-like E. coli strain, such as K-12 strain MG1655, which is deficient for LPS O-antigen expression, may be enhanced by E. faecalis-mediated immune modulation (43) . To test this, we infected catheterized mice with 10 7 CFU of E. coli K-12 strain MG1655 alone or 10 7 CFU each of E. coli and E. faecalis (equal ratio). Similar to the results for infection with UTI89, the number of E. coli CFU at 24 hpi was not different following coinfection with E. faecalis in the bladder from that for E. coli monospecies infection, and the number of E. faecalis CFU was significantly decreased (Fig. 5C) . In contrast, the number of E. coli CFU was significantly increased in the kidneys following coinfection with E. faecalis, while the number of E. faecalis CFU was unchanged (Fig.  5D ). Collectively, these infection studies show that the presence of immunomodulatory organisms, such as E. faecalis, in the context of a polymicrobial CAUTI can increase the pathogenicity of otherwise nonvirulent infectious organisms and increase host vulnerability to infection by otherwise commensal organisms.
DISCUSSION
Bacterial immunomodulatory functions can alter infection sites, leading to increased susceptibility to colonization and persistence (16, 44) . E. faecalis can augment the immune response in a variety of cell types, including intestinal epithelial and mouse macrophage cell lines (14-16). Recently, it was shown that E. faecalis strains V583 and E99 suppress NF-B activation of intestinal epithelial cells and RAW264.7 macrophages at an MOI of 100 (13) (14) (15) (16) . In contrast to reports of high-MOI immune suppression by V583 and E99, infection of RAW264.7 macrophages and bone marrow-derived macrophages with E. faecalis strain E99 at an MOI of 10 results in NF-B activation (13) (14) (15) (16) . These discrepant reports of NF-B activation and suppression by E. faecalis underscore the need for further investigation into E. faecalis immunomodulatory activities within macrophages. Here we resolve previous conflicting reports and show that both E. faecalis strains V583 and OG1RF prevent NF-B activity in RAW264.7 macrophages in a dose-dependent manner.
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coli-infected compared to polymicrobial species-infected animals) that were placed within the top 1% of the distribution of the cell type-specific enrichment scores (73) (purple dots) compared to those for 100 sets of 50 expressed genes drawn at random (gray dots; the violin plot in yellow summarizes the overall distribution, and the vertical bar shows the level of the median). SP, stem and progenitor cells; B, B cells; DC, dendritic cells; MF, macrophages; MO, monocytes; GN, granulocytes; T4, CD4 ϩ cells; T8, CD8 ϩ cells; NKT, natural killer T cells; GDT, ␥␦ T cells; SC, stromal cells; NK, natural killer cells. See Tables S1 and S2 in the supplemental material for related analyses. The experiment was performed twice (n ϭ 3 mice per group per experiment). Representative data from one experiment are shown.
Several E. faecalis virulence factors modulate immunity during infection, including aggregation substance (AS), gelatinase, and TcpF (16) (17) (18) (19) . The E. faecalis OG1RF strain used in this study lacks the plasmid encoding AS, so AS is not the immunomodulatory factor in this work. In addition, it was shown previously that gelatinase as well as the fsr quorum sensing system that regulates gelatinase expression does not contribute to NF-B immunomodulation (25, 36) . Finally, TcpF is present in E. faecalis V583 and enriched in UTI isolates, but it is absent in OG1RF (16, 20) . Since we observed NF-B modulation by both E. faecalis OG1RF and V583, TcpF is unlikely to be the factor mediating high-level NF-B suppression in macrophages. Instead, our data suggest that the E. faecalis factor which prevents NF-B activity is a previously uncharacterized, heat-modifiable molecule. Other Gram-positive pathogens secrete heat-modifiable immunomodulatory molecules. For example, Staphylococcus aureus superantigen-like proteins (SSLs) have immunomodulatory functions, such as inhibiting IgA-mediated immune responses and targeting neutrophils to limit attachment to endothelial cells (45) (46) (47) (48) (49) (50) . SSL3 can downregulate TLR2-mediated production of IL-8 by binding competitively with PAMP ligands of TLR2 (51). Our work indicates that E. faecalis may possess similar secreted factors that modulate NF-B activation and prevent bacterial clearance by host immune cells.
A large proportion of E. faecalis infections are polymicrobial, and E. faecalis is frequently coisolated with E. coli from urinary tract and wound infections (35, 44, Significance was determined by the nonparametric Mann-Whitney U test. *, P Ͻ 0.05; **, P Ͻ 0.01. The dashed horizontal line represents the limit of detection (LOD) of the assay. Titers below the LOD were assigned the value of the LOD for visualization on the log scale and a value of 0 for statistical analyses. [52] [53] [54] . Given the prevalence of E. faecalis in polymicrobial interactions, we performed in vitro and in vivo experiments to study the contribution of E. faecalis to coinfection outcomes. We found that E. faecalis prevented NF-B activity during coinfection with live E. coli K-12 strain MG1655 and UPEC strain UTI89 in vitro and augmented E. coli K-12 strain MG1655 titers in the kidneys. However, we did not observe E. faecalis-mediated augmentation of CAUTI for UPEC strain UTI89. We propose that this is because E. coli UTI89 is already highly virulent and inflammatory in vivo, so E. faecalis-mediated immune suppression cannot overcome such a strong proinflammatory response. Rather, our data suggest that E. faecalis may help to increase the fitness of less virulent or commensal strains, such as E. coli MG1655. Similar to our findings in this study, the Gram-positive uropathogens Staphylococcus saprophyticus and group B streptococcus induce minimal proinflammatory responses in the urinary tract, and the latter suppresses proinflammatory responses in vitro and limits UPEC pathogenesis in mice (42, 44, (55) (56) (57) . Taken together, our findings suggest that E. faecalis modulation of the immune response may promote the survival of commensal bacteria, which increases the chance of UTI.
Synergistic polymicrobial infections are increasingly recognized for their contributions to both disease severity and persistence (31, 44) . Here we show that E. faecalis modulates the host response and promotes infection by a coinfecting E. coli strain which is otherwise nonvirulent. Importantly, the presence of E. faecalis in the urinary tract, especially when titers are low, has historically been considered a commensal contaminant of questionable pathogenic significance (58) . Our findings call into question that supposition and raise the prospect that E. faecalis not only augments some E. coli infections but also may also promote infection by a larger spectrum of less fit or commensal E. coli strains, similar to the effect exerted by group B streptococcus (42) . Continued efforts are needed to dissect these polymicrobial molecular interactions to allow for better diagnostics and precision treatment, especially as UTI pathogens are increasingly resistant to antibiotics of last resort (59) .
MATERIALS AND METHODS
Bacterial strains and growth conditions. Uropathogenic E. coli (UPEC) strain UTI89 (60, 61) and E. coli K-12 strain MG1655,which is an LPS mutant strain (43, 62) , were grown overnight in Luria-Bertani (LB) broth or agar at 37°C under static conditions. E. faecalis strains OG1RF (63) and V583 (64) were grown statically in brain heart infusion (BHI) broth or agar at 37°C overnight. Overnight cultures of bacteria were centrifuged at 6,000 ϫ g for 5 min and resuspended in phosphate-buffered saline (PBS) to an optical density at 600 nm (OD 600 ) of 0.7 (2 ϫ 10 8 CFU/ml) for E. faecalis and an OD 600 of 0.4 (2 ϫ 10 8 CFU/ml) for E. coli.
Cell culture. RAW-Blue cells, derived from RAW264.7 macrophages (Invivogen) and containing a plasmid encoding a secreted embryonic alkaline phosphatase (SEAP) reporter under transcriptional control of an NF-B-inducible promoter, were cultivated in Dulbecco modified Eagle medium containing 4,500 mg/liter glucose (high glucose; 1ϫ) with 4.0 mM L-glutamine, without sodium pyruvate (Gibco) and supplemented with 10% fetal bovine serum (FBS; PAA) supplemented with 200 g/ml Zeocin at 37°C in 5% CO 2 .
RAW-Blue macrophage infection. RAW-Blue cells were seeded in a 96-well plate at 100,000 cells/well in 200 l of antibiotic-free cell culture medium. Following overnight incubation, the cells were washed once with PBS, and fresh medium was added. The SEAP reporter assay was established by empirically defining the minimal agonist (LPS or lipoteichoic acid [65] ) concentration that induced the maximum SEAP activity in the absence of cell death. Cells were stimulated using EB ultrapure LPS purified from E. coli O111:B4 (100 ng/ml) (Invivogen) or LTA derived/purified from Staphylococcus aureus (100 ng/ml) (Invivogen) as a positive control or medium alone as a negative control. RAW-Blue cells were infected with E. faecalis (at MOIs of 100:1, 50:1, 25:1, 10:1, and 1:1) for 6 h, with or without TLR agonists. Overnight bacterial cultures were centrifuged and resuspended in cell culture medium. For infection experiments, live bacterial cultures were diluted to achieve the desired MOI with macrophages. Alternatively, bacteria were heat killed (80°C for 1 h) prior to addition to macrophage cultures. For coinfection experiments, RAW-Blue cells were simultaneously infected with E. coli K-12 strain MG1655 (MOI of 1:1) or E. coli UTI89 (MOI of 0.125:1) and E. faecalis OG1RF (MOIs of 100:1, 50:1, 25:1, 10:1, and 1:1). Heat-killed bacteria were verified by the absence of viable bacteria on BHI agar.
Collection of bacterial cell-free culture supernatants. Bacteria were grown in cell culture medium for 6 h, and bacterium-free culture supernatants were collected after centrifugation (6,000 ϫ g) followed by filtration (using a 0.2-m syringe filter). Alternatively, supernatants were collected after infecting macrophages with bacteria at various MOIs and then filtered by use of a 0.2-m syringe filter. Sterility of bacterium-free culture supernatants was verified by the absence of viable bacteria on BHI agar. NF-B reporter assay. Postinfection, 20 l of supernatant was added to 180 l of Quanti-Blue reagent (Invivogen) and incubated overnight at 37°C. SEAP levels were determined at 640 nm by using a Tecan M200 microplate reader. All experiments were performed in triplicate.
Cell viability assay. Simultaneously with supernatant collection for SEAP determination, culture supernatants were collected from each well to measure lactate dehydrogenase (LDH) release by using an LDH cytotoxicity assay (Clontech) according to the manufacturer's instructions. Background LDH activity was determined using mock (PBS)-treated RAW-Blue cells. Maximal LDH activity was determined by lysing cells with 1% Triton X. Each condition was carried out in triplicate. The percentage of cytotoxicity was calculated as follows: % cytotoxicity ϭ [(sample absorbance Ϫ background absorbance)/(maximal absorbance Ϫ background absorbance)] ϫ 100.
Luminex MAP analysis. Supernatants were collected from RAW-Blue cells at 6 h postinfection and stored at Ϫ80°C until assessment by use of a Bio-Plex Pro mouse cytokine 23-plex assay kit (Bio-Rad Laboratories) according to the manufacturer's recommendations (66) . All samples were assessed using the same kit lot and at the same time to avoid interassay variability.
Catheterization and bacterial infections. Catheters were implanted into bladders of mice, followed by bacterial inoculation via a transurethral catheter, as previously described (28, 67) . Briefly, 6-to 8-week-old female C57BL/6NTac mice (InVivos Pte Ltd., Singapore) were anesthetized with isoflurane (4%). Inoculum volumes of 50 l contained bacterial suspensions of either single or polymicrobial species prepared in PBS, as follows: (i) 10 7 CFU of E. coli K-12 strain MG1655 with 10 7 CFU of E. faecalis OG1RF and (ii) 10 7 CFU of E. coli UTI89 with 10 7 CFU of E. faecalis OG1RF. Single-species control infections (10 7 CFU of E. coli K-12 strain MG1655, 10 7 CFU of E. faecalis OG1RF, or 10 7 CFU of E. coli UTI89) were performed alongside polymicrobial infections. Animals were euthanized by carbon dioxide inhalation and cervical dislocation, and bladders and kidneys were aseptically removed and homogenized in 1 ml PBS for CFU enumeration by serial dilution on MacConkey agar or on BHI agar supplemented with 10 g/ml colistin and 10 g/ml nalidixic acid to isolate E. coli or E. faecalis, respectively. To identify bacterial species other than the inoculated E. coli or E. faecalis organisms, serial dilutions were also plated on LB and BHI agar. Animals in which other organisms were found were excluded from our analysis. Data from 2 independent experiments (5 to 7 mice per group) were combined. Animals without catheters at the time of sacrifice were not included in the analyses.
RNA sequencing of RNAs from infected bladders. Catheterized mice were infected as described above with 10 7 CFU of E. coli UTI89, alone or mixed at a 1:1 ratio with 10 7 CFU of E. faecalis OG1RF, in 50 l PBS. After 24 h, whole bladders were removed and incubated overnight in RNAlater (Qiagen) to allow complete tissue penetration by the protectant prior to storage at Ϫ80°C. RNA was extracted as described previously (29) . For each sample condition, a total of three sequence libraries were constructed from 50 to 200 ng of rRNA-depleted RNA. Each library (2 nM) was pooled at equal volumes and sequenced using an Illumina Hiseq2500 v.2 sequencer (Illumina), giving 150-bp paired-end sequences.
Analysis of RNA sequencing data. RNA sequencing results were analyzed as described previously (29) . Briefly, reads were quality checked and adapters trimmed with cutadapt-1.4.1, using default parameters. The mm10 mouse genome was used as a reference for tophat-2.0.11.Linux_x86_64 (68) , and transcriptional read counts were obtained using HTSeq-0.6.1 (69) with default parameters, using a nonstranded analysis. Unless otherwise stated, all further analyses were performed in the R statistical computing environment (version 3.3.3) (70) . Differential analysis of E. coli monospecies-infected animals and E. coli-and E. faecalis OG1RF-coinfected animals was performed using the R/Bioconductor package DESeq2 (version 1.40.1) (71), using default settings from that package. The NCBI file gene2refseq (downloaded 3 March 2016) was used to convert Refseq identifiers to Entrez identifiers for further analysis of Gene Otology annotations and Immunological Genome Project (ImmGen) data for functional analysis.
Functional analysis of the bladder transcriptome. Processing of ImmGen expression data was performed in R 3.2.2 (70) . Briefly, all 681 CEL files (72) were processed using the RMA method with the R/Bioconductor package oligo (version 1.34.0). Annotation was done using the R/Bioconductor package mogene10sttranscriptcluster.db (version 8.4.0), with expression profiles for immune cell types referenced from the work of Jojic et al. (72) . An enrichment score was calculated for each immune cell type (73), and we examined differentially expressed genes in the top 1% of the score distribution for each cell type and compared these to equally sized cohorts of randomly selected genes (see Table S2 in the supplemental material). This analysis was conducted separately with up-and downregulated gene sets in the two-group comparison. Ontology analysis was performed using the R/Bioconductor package GO.db (version 3.4.0) and the gene2go file from the NCBI Gene database (downloaded 3 March 2016), using modified code from the R/Bioconductor package ontoTools (version 1.28.0) (74) . To test if differentially expressed genes associated with specific gene sets, we constructed 2-by-2 contingency tables and categorized genes based on whether they were differentially expressed or not for each included Gene Ontology biological process (GOBP) term. Random assignment was tested using Fisher's exact test (75) and corrected for the number of terms by use of the Benjamini-Hochberg correction (76) . We filtered terms by using their information content (IC) (77) , based on a frequency of occurrence between 3 and 4, resulting in a set of 157 included terms that represent an appropriate trade-off between the total number of included terms and the specificity of functional insight. The entire R workflow and input data files are available online (https://github.com/rbhwilliams/Kline-polymicrobial-infection-paper).
Statistical analysis. Statistical analyses were performed using GraphPad Prism software (version 6.05 for Windows). SEAP assays were analyzed using one-way analysis of variance (ANOVA) with Tukey's post hoc test for multiple comparisons. Cytokine readings for Luminex MAP analysis were analyzed using the Kruskal-Wallis test. CFU titers were compared using the nonparametric Mann-Whitney U test. P values of Ͻ0.05 were deemed significant. Cytokine comparisons were performed using the Mann-Whitney U test, and further comparison was done using principal component analysis in R (version 3.3.2), with the packages factoextra (version 1.0.4) and FactoMineR (version 1.34). Heat map data reflect log 2 transformation of the raw data and were plotted in R (version 3.3.2) by using the R package pheatmap (version 1.0.8).
Ethics statement. Mouse experiments were performed with ethical approval by the Nanyang Technological University Institutional Animal Care and Use Committee (protocol ARF-SBS/NIE-A0247), which adheres to the National Advisory Committee for Laboratory Animal Research (NACLAR), a national guide which establishes the best practices for the use and care of animals for scientific purposes. Accession number(s). RNA sequencing data from this study are available at NCBI's BioProject under accession no. PRJNA335539.
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